GlassScriptPhysician profile
Jennifer Brooks
NPI 1487934162
$1,376.80
in general payments reported to CMS, 2019-2025
19 companies · $716 in 2025
The $716 reported for 2025 was more than what 79% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.25 · 2023: $180 · 2024: $444 · 2025: $716.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,340.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lundbeck LLC | $189.79 | 2023-2025 | Rexulti, Vyepti |
| Novo Nordisk INC | $182.17 | 2024-2025 | Ozempic, Rybelsus, Wegovy |
| Lilly USA, LLC | $156.99 | 2023-2025 | Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $154.48 | 2024-2025 | Airsupra |
| Otsuka America Pharmaceutical, INC. | $140.68 | 2023-2025 | Rexulti |
| Abbvie INC. | $94.84 | 2021-2025 | |
| Amgen INC. | $85.02 | 2024-2025 | Evenity, Prolia |
| Exact Sciences Corporation | $59.64 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Pfizer INC. | $57.53 | 2023-2025 | |
| Shield Therapeutics INC | $47.43 | 2025 | |
| Atricure, INC. | $34.24 | 2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Boston Scientific Corporation | $32.35 | 2023 | |
| Amarin Pharma, INC. | $25.04 | 2021 | |
| Viatris Specialty LLC | $22.34 | 2025 | Yupelri |
| Abbott Laboratories | $22.20 | 2024 | Freestyle Libre 3 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $20.62 | 2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $17.93 | 2024 | Voquezna |
| Irhythm Technologies, INC. | $17.56 | 2024 | Zio Monitor, Zio Xt Patch |
| Glaxosmithkline, LLC. | $15.95 | 2025 | Trelegy Ellipta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Brooks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.